The European Commission has approved a new subcutaneous (under-the-skin) formulation of Sarclisa (isatuximab), a treatment for multiple myeloma…
Articles by Marisa Wexler, MS
The U.S. Food and Drug Administration (FDA) has approved a new formulation of the anticancer therapy nilotinib, branded Cavhanza, to…
Ideaya Biosciences and Roche announced a collaboration to test two experimental treatments for pancreatic cancer in combination.
Add-on treatment with DeltEx DRI, a cell therapy being developed by In8bio, may help prolong survival in people with…
A combination of the immune-modulating treatments Lymphir (denileukin diftitox) and Keytruda (pembrolizumab) led to clinical benefit in nearly half of…
Treatment with a regimen based on the experimental therapy mezigdomide reduced the risk of disease progression or death by more…
The U.S. Food and Drug Administration (FDA) has granted fast-track designation to STX-0712, an experimental therapy Solu Therapeutics is…
The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to an experimental delivery method for the chemotherapy…
An experimental therapy designed to mimic vitamin B12 and deliver a toxic molecule to tumor cells showed promise as a…
The experimental cancer vaccine Tedopi (OSE2101), when given in combination with the approved injection therapy Keytruda (pembrolizumab), outperforms…